Brompheniramine Maleate + Phenylpropanolamine HCl
Product Description
Osmopharm S.A.
-
Country/Region:Switzerland
-
On CPHI since:2015
Specifications
Osmopharm S.A.
-
Country/Region:Switzerland
-
On CPHI since:2015
More Products from Osmopharm S.A. (99)
-
Product Atenolol
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes atenolol. It belongs to antihypertensive category. Bulk physical form: pellets, microcapsules. Final dosage form: caps/tabs. Contact us for more information. -
Product Benproperine
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes benproperine. It belongs to antitussive category. Bulk physical form: resinates. Final dosage form: caps/tabs. Contact us for more information. -
Product Betahistine 2HCI
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes betahistine 2HCI. It belongs to vasodilator category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Bromopride
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes bromopride. It belongs to antiemetic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Brompheniramine maleate
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes brompheniramine maleate. It belongs to antihistaminic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Brompheniramine Maleate + Phenylephrine HCI
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes brompheniramine maleate + phenylephrine HCI. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Caffeine
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes caffeine. It belongs to CNS stimulant category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Caffeine + Dimenhydrinate + Phenylephrine HCI
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes caffeine + dimenhydrinate + phenylephrine HCI. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Caffeine + Diphenihydramine HCl
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes caffeine + diphenihydramine HCl. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Caffeine + Meclozine + Pyridoxine HCI
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes caffeine + meclozine + pyridoxine HCI. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Carbetapentane citrate
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes carbetapentane citrate. It belongs to antitussive category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information. -
Product Carbinoxamine maleate
Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes carbinoxamine maleate. It belongs to antihistaminic category. Bulk physical form: pellets, resinates. Final dosage form: caps/tabs. Contact us for more information.